Global emergence of Pseudomonas fluorescens (P. fluorescens) displays a mechanism of resistance to all existing antimicrobials. Due to its strong ability to acquire resistance, there is a need of some alternative treatment strategy. Objective of this study was to investigate the effect of biofield treatment on antimicrobial sensitivity pattern of P. fluorescens. P. fluorescens cells were procured from MicroBioLogics in sealed packs bearing the American Type Culture Collection (ATCC 49838) number. Two sets of ATCC samples were taken in this experiment and denoted as A and B. ATCC-A sample was revived and divided into two groups (Gr) i.e. Gr.I (control) and Gr.II (revived); likewise, ATCC-B was labeled as Gr.III (lyophilized). Gr.II and III were given biofield treatment and were measured by MicroScan Walk-Away® system before and after treatment. Parameters studied in experiment were antimicrobial sensitivity, minimum inhibitory concentration (MIC), biochemical reactions, and biotype number of both control and treatment groups using MicroScan Walk-Away® system. Experimental results showed antimicrobials such as cefepime, cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, piperacillin, tetracycline, and tobramycin showed altered sensitivity and MIC values in treated group as compared to control. Biochemical reactions showed positive reaction in malonate, melibiose, nitrate, galactosidase, ornithine, raffinose, sorbitol, sucrose, tobramycin and Voges-Proskauer in Gr.II. Arabinose, colistin, glucose, and rhaminose also showed positive reactions in Gr.II on day 10 while arginine and cetrimide showed negative reaction in Gr.III as compared to control. Biochemical tests results revealed a change in biotype number in Gr.II (34101173, day 5), (77103177, a very rare biotype on day 10) and Gr.III (40000043) as compared to control (02041722). Organism was identified as Enterobacter cloacae (GrII, day 10) and Vibrio fluvialis (Gr.III, day 10) with respect to control. These findings suggest that biofield treatment made significant alteration in sensitivity pattern, MIC values, and biotype number of P. fluorescens.
1. Pittman M (1953) A study of bacteria implicated in transfusion reactions and of bacteria isolated from blood products. J Lab clin Med 42: 273-288.
2. Madi A, Lakhdari O, Blottière HM, Guyard-Nicodeme M, Le Roux K, et al. (2010) The clinical Pseudomonas fluorescens MFN1032 strain exerts a cytotoxic effect on epithelial intestinal cells and induces Interleukin-8 via the AP-1 signaling pathway. BMC Microbiol 10: 215.
3. Farquhar MG, Palade GE (1963) Junctional complexes in various epithelia. J Cell Biol 17: 375-412.
4. Rajmohan S, Dodd CE, Waites WM (2002) Enzymes from isolates of Pseudomonas fluorescens involved in food spoilage. J Appl Microbiol 93: 205-213.
5. Sutton CL, Kim J, Yamane A, Dalwadi H, Wei B, et al. (2000) Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology 119: 23-31.
6. Benor DJ (2002) Energy medicine for the internist. Med Clin North Am 86: 105-125.
7. Jonas WB, Crawford CC (2003) Science and spiritual healing: a critical review of spiritual healing, “energy” medicine, and intentionality. Altern Ther Health Med 9: 56-61.
8. Einstein A (1905) Does the inertia of a body depend upon its energy-content. Ann Phys 18: 639-641.
9. Trivedi MK, Patil S (2008) Impact of an external energy on Staphylococcus epidermis [ATCC-13518] in relation to antibiotic susceptibility and biochemical reactions-an experimental study. J Accord Integr Med 4: 230-235.
10. Trivedi MK, Patil S (2008) Impact of an external energy on Yersinia enterocolitica [ATCC-23715] in relation to antibiotic susceptibility and biochemical reactions: an experimental study. Internet J Alternat Med 6: 13.
11. Trivedi MK, Bhardwaj Y, Patil S, Shettigar H, Bulbule A (2009) Impact of an external energy on Enterococcus faecalis [ATCC-51299] in relation to antibiotic susceptibility and biochemical reactions-an experimental study. J Accord Integr Med 5: 119-130.
12. Running A (2015) Decreased cortisol and pain in breast cancer: Biofield therapy potential. Evid Based Complement Alternat Med.
13. Yount G, Patil S, Dave U, Alves-dos-Santos L, Gon K, et al. (2013) Evaluation of biofield treatment dose and distance in a model of cancer cell death. J Alternat Complement Med 19: 124-127.
14. Chen KW (2008) Inhibitory effects of bio-energy therapies on cancer growth. World Sci Tech Modern Trad Chin Med 10: 144-152.
15. Dabhade VV, Tallapragada RR, Trivedi MK (2009) Effect of external energy on atomic, crystalline and powder characteristics of antimony and bismuth powders. Bull Mat Sci 32: 471-479.
16. Trivedi MK, Patil S, Tallapragada RM (2012) Thought Intervention through biofield changing metal powder characteristics experiments on powder characterisation at a PM Plant, Springer Berlin Heidelberg. Lecture Notes in Electrical Engineering-Future Control and Automation 173: 247-252.
17. Shinde V, Sances F, Patil S, Spence A (2012) Impact of biofield treatment on growth and yield of lettuce and tomato. Austral J Bas App Sci 6: 100-105.
18. Sances F, Flora E, Patil S, Spence A, Shinde V (2013) Impact of biofield treatment on ginseng and organic blueberry yield. AGRIVITA J Agri Sci 35: 22-29.
19. Lenssen AW (2013) Biofield and fungicide seed treatment influences on soybean productivity, seed quality and weed community. Agric J 8: 138-143.
20. Fader RC, Weaver E, Fossett R, Toyras M, Vanderlaan J, et al. (2013) Multilaboratory study of the biomic automated well-reading instrument versus MicroScan WalkAway for reading MicroScan antimicrobial Susceptibility and identification panels. J Clin Microbiol 51: 1548-1554.
21. Gomaa FM, Tawakol WM, Abo El-Azm FI (2014) Phenotypic and genotypic detection of some antimicrobial resistance mechanisms among multidrug-resistant Acinetobacter baumannii isolated from immunocompromised patients in Egypt. Egypt J Med Microbiol 23: 99-111.
22. Wong V, Levi K, Baddal B, Turton J, Boswell T (2011) Spread of Pseudomonas fluorescens due to contaminated drinking water in a bone marrow transplant unit. J Clin Microbiol 49: 2093-2096.
23. Chapalain A, Rossignol G, Lesouhaitier O, Merieau A, Gruffaz C, et al. (2007) Comparative study of 7 fluorescent pseudomonad clinical isolates. Canad J Microbiol 54: 19-27.
24. Picot L, Abdelmoula SM, Merieau A, Lerouxb P, Cazina L, et al. (2001) Pseudomonas fluorescens as a potential pathogen: adherence to nerve cells. Microb & Infect 3: 985-995.
25. Madi A, Svinareff P, Orange N, Feuilloley MG, Connil N (2010) Pseudomonas fluorescens alters epithelial permeability and translocates across Caco-2/TC7 intestinal cells. Gut Pathog 2: 1-8.
26. Morgan A (2014) The synergistic effect of gentamicin and ceftazidime against Pseudomonas fluorescens. Bioscience Horizons 7: hzu007.
27. Phillip I (1969) Identification of Pseudomonas aeruginosa in the clinical laboratory. J Med Microbiol 2: 9-16.
28. Giasson M, Bouchard L (1998) Effect of therapeutic touch on the well-being of persons with terminal cancer. J Holist Nurs 16: 383-398.
29. Peck SD (1998) The efficacy of therapeutic touch for improving functional ability in elders with degenerative arthritis. Nurs Sci Q 11: 123-132.
30. Turner JG, Clark AJ, Gauthier DK, Williams M (1998) The effect of therapeutic touch on pain and anxiety in burn patients. J Adv Nurs 28: 10-20.
31. Oschman JL (2002) Clinical aspects of biological fields: an introduction for health care professionals. J Bodyw Mov Ther 6: 117-125.
32. Lindstrom E, Hansson M, Lundgren E (1998) Analysis of the T cell activation signaling pathway during ELF magnetic field exposure, p56lck and [Ca2+]i-measurements. Bioeletrochem Bioenerg 46: 129-137.
33. Lindstrom E, Still M, Mattsson M, Mild KH, Luben RA (2000) ELF magnetic fields initiate protein tyrosine phosphorylation of the T cell receptor complex. Bioelectrochemistry 53: 73-78.
Cite this work
Researchers should cite this work as follows:
Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) Antimicrobial Sensitivity Pattern of Pseudomonas fluorescens after Biofield Treatment. J Infect Dis Ther 3: 222. doi:10.4172/2332-0877.1000222.